20 Bio, Inc.
Last verified 2026-05-05. JSON
| Total raised | $3.0M |
|---|---|
| Latest round | Funding round, $4.5M, 2026-02-13 |
| Founded | 2021 |
| Headquarters | SOMERVILLE, MA |
| Industry | bio |
| Stage | unknown |
| Website | 20bio.com |
20 Bio is a biotechnology company developing diagnostic and life-science products under the 20bio.com domain. It is aimed at the clinical and research market for early detection and disease-risk management. Public information about its current pipeline and team is limited.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-02-13 | Funding round | $4.5M | undisclosed |
Provenance
| Fact | Status | Basis |
|---|---|---|
| Funding round, $4.5M | sourced | SEC EDGAR named as publisher. Document, retrieved 2026-09-25. |
| Total raised $3.0M | sourced | SEC EDGAR named as publisher. Document, retrieved 2026-09-25. |
| Company existence | self-reported | 20bio.com, read 2026-05-05 |
| Description | self-reported | 20bio.com, read 2026-05-05 |
Change history
| Date | Fact | Change | Basis |
|---|---|---|---|
| 2026-09-25Latest round: seed, $4.5M, 2026-02-13 → Funding round, $4.5M, 2026-02-13, SEC EDGAR, document, retrieved 2026-09-25 | Latest round | seed, $4.5M, 2026-02-13 → Funding round, $4.5M, 2026-02-13 | SEC EDGAR, document, retrieved 2026-09-25 |
| 2026-09-25Round: attributed → sourced, SEC EDGAR, document, retrieved 2026-09-25 | Round | attributed → sourced | SEC EDGAR, document, retrieved 2026-09-25 |
Records begin 2026-09-24. All changes